![Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1038%2Fs41375-022-01729-4/MediaObjects/41375_2022_1729_Fig1_HTML.png)
Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal
![Frontiers | Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors Frontiers | Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors](https://www.frontiersin.org/files/Articles/769612/fonc-11-769612-HTML/image_m/fonc-11-769612-g001.jpg)
Frontiers | Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
![Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-019-0186-8/MediaObjects/41408_2019_186_Fig1_HTML.png)
Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal
![Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human ( IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human ( IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol](https://www.jove.com/files/ftp_upload/54139/54139fig4large.jpg)
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human ( IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol
![Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human ( IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human ( IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol](https://www.jove.com/files/ftp_upload/54139/54139fig5large.jpg)
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human ( IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol
![Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human ( IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human ( IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study | Protocol](https://www.jove.com/files/ftp_upload/54139/54139fig1large.jpg)